List of Excipients in API norethindrone acetate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing norethindrone acetate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| RPK Pharmaceuticals Inc | MICROGESTIN 1/20 | norethindrone acetate and ethinyl estradiol | 53002-1549 | ACACIA | |
| RPK Pharmaceuticals Inc | MICROGESTIN 1/20 | norethindrone acetate and ethinyl estradiol | 53002-1549 | LACTOSE | |
| RPK Pharmaceuticals Inc | MICROGESTIN 1/20 | norethindrone acetate and ethinyl estradiol | 53002-1549 | MAGNESIUM STEARATE | |
| RPK Pharmaceuticals Inc | MICROGESTIN 1/20 | norethindrone acetate and ethinyl estradiol | 53002-1549 | STARCH, CORN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing norethindrone acetate
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 | ANHYDROUS LACTOSE |
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 | CELLULOSE, MICROCRYSTALLINE |
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 | LACTOSE MONOHYDRATE |
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 | MAGNESIUM STEARATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for norethindrone acetate
Excipient focus: .ALPHA.-TOCOPHEROL
norethindrone acetate drug variants containing .ALPHA.-TOCOPHEROL
norethindrone acetate drug variants not containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: .ALPHA.-TOCOPHEROL, DL-
norethindrone acetate drug variants containing .ALPHA.-TOCOPHEROL, DL-
norethindrone acetate drug variants not containing .ALPHA.-TOCOPHEROL, DL-
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: ACACIA
norethindrone acetate drug variants containing ACACIA
norethindrone acetate drug variants not containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
norethindrone acetate drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | norethindrone acetate and ethinyl estradiol | 54868-6272 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
norethindrone acetate drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Teva Women's Health LLC | norethindrone acetate | 51285-424 |
| Golden State Medical Supply Inc | norethindrone acetate | 51407-599 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CALCIUM STEARATE
norethindrone acetate drug variants containing CALCIUM STEARATE
norethindrone acetate drug variants not containing CALCIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
norethindrone acetate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
norethindrone acetate drug variants containing CROSCARMELLOSE SODIUM
norethindrone acetate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 30
norethindrone acetate drug variants containing D&C RED NO. 30
| Company | Ingredient | NDC |
|---|---|---|
| Glenmark Pharmaceuticals Inc USA | norethindrone acetate and ethinyl estradiol | 68462-656 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing D&C RED NO. 30
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
norethindrone acetate drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | norethindrone acetate and ethinyl estradiol | 65862-939 |
| Glenmark Pharmaceuticals Inc USA | norethindrone acetate and ethinyl estradiol | 68462-504 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
norethindrone acetate drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
norethindrone acetate drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
norethindrone acetate drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 0378-7274 |
| Glenmark Pharmaceuticals Inc USA | norethindrone acetate and ethinyl estradiol | 68462-504 |
| Xiromed LLC | norethindrone acetate and ethinyl estradiol | 70700-314 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
norethindrone acetate drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | norethindrone acetate and ethinyl estradiol | 54868-6272 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
norethindrone acetate drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Glenmark Pharmaceuticals Inc USA | norethindrone acetate and ethinyl estradiol | 68462-504 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
norethindrone acetate drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Nivagen Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 75834-130 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
norethindrone acetate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Nivagen Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 75834-130 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
norethindrone acetate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 68180-827 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
norethindrone acetate drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Glenmark Pharmaceuticals Inc USA | norethindrone acetate and ethinyl estradiol | 68462-656 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
norethindrone acetate drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| RPK Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 53002-1549 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
norethindrone acetate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| Glenmark Pharmaceuticals Inc USA | norethindrone acetate | 68462-304 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
norethindrone acetate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALTODEXTRIN
norethindrone acetate drug variants containing MALTODEXTRIN
norethindrone acetate drug variants not containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
norethindrone acetate drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Nivagen Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 75834-130 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 300
norethindrone acetate drug variants containing POLYETHYLENE GLYCOL 300
| Company | Ingredient | NDC |
|---|---|---|
| Nivagen Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 75834-130 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing POLYETHYLENE GLYCOL 300
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
norethindrone acetate drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 68180-827 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K25
norethindrone acetate drug variants containing POVIDONE K25
norethindrone acetate drug variants not containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
norethindrone acetate drug variants containing POVIDONE K30
norethindrone acetate drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
norethindrone acetate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Glenmark Pharmaceuticals Inc USA | norethindrone acetate | 68462-304 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
norethindrone acetate drug variants containing SODIUM LAURYL SULFATE
norethindrone acetate drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
norethindrone acetate drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | norethindrone acetate and ethinyl estradiol | 0093-3122 |
| Physicians Total Care Inc | norethindrone acetate and ethinyl estradiol | 54868-6251 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
norethindrone acetate drug variants containing STARCH, CORN
norethindrone acetate drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
norethindrone acetate drug variants containing SUCROSE
norethindrone acetate drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
norethindrone acetate drug variants containing TALC
norethindrone acetate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
norethindrone acetate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 68180-827 |
| Nivagen Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 75834-130 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: TOCOPHEROL
norethindrone acetate drug variants containing TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 68180-827 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
norethindrone acetate drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Nivagen Pharmaceuticals Inc | norethindrone acetate and ethinyl estradiol | 75834-130 |
| >Company | >Ingredient | >NDC |
norethindrone acetate drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | norethindrone acetate | 0378-7291 |
| Teva Pharmaceuticals USA Inc | norethindrone acetate | 0555-0211 |
| Rising Pharmaceuticals Inc | norethindrone acetate | 16571-658 |
| Ingenus Pharmaceuticals LLC | norethindrone acetate | 50742-267 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
